Form D Explorer
Lexaria Bioscience Corp. · CIK 1348362

Report a data issueCitable research briefCompare issuerPrivate research collection

Lexaria Bioscience Corp.

CIK 1348362 · Corporation · Inc. NEVADA · KELOWNA, British Columbia, Canada · Biotechnology

These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.

Filing history at a glance

The reported offering amount was $3,500,004 in the Dec 19, 2025 filing and $113,492 in the Sep 21, 2026 filing. The two records may concern different offerings. All 3 stored filings from Oct 1, 2025 to Sep 21, 2026 are original notices.

Filings
3
Original notices
3
Amendments
0
Activity
Oct 1, 2025
through Sep 21, 2026

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Differences between reported disclosures

Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.

Unavailable values are shown as a dash; reported zero remains zero.
FieldDec 19, 2025 · DSep 21, 2026 · DLater minus earlier
Reported offering amount$3,500,004$113,492$-3,386,512
Reported amount sold$3,500,004$113,492$-3,386,512
Reported investor count—3—
Reported minimum investment$0$0$0

Earlier SEC source: 0001348362-25-000018 · Later SEC source: 0001348362-26-000002

Choose filings to compare · Research this issuer step by step

Latest available filing snapshot: how to read these fields

Form D · Sep 21, 2026

Reported offering amount
$113,492
Reported exemptions
Rule 506(b)
Reported amount sold
$113,492

This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.

Filings by year

Submission counts, including amendments; not dollars raised or distinct funding rounds.

Same reported sales compensation recipient

Matches in stored disclosures are research leads. They do not establish common ownership or confirm identity.

Form D filings (3)